Truebloodthe Trueblood Seminars offer educators the opportunity to learn from and network with Deloitte professionals who share their experiences and institutional knowledge which professors can take back to the classroom to better prepare students for their future careers.
While this topic is outside the scope of this case, authoritative accounting literature supports several alternative views on how to account for these scenarios. Named after Robert M. As noted in Addendum — above, the conclusions reached in the above case were not affected by ASC Statement ; however, ASC Statement may affect how Ace Company measures the fair value of the forward purchase contract and, therefore, how the proceeds are allocated between the purchase contract and the note.
These seminars help professors enrich the accounting curriculum to reflect the necessary skills of the auditor of the future. The Deloitte Foundation also offers case studies covering fraud related topics. Access Trueblood case solutions To obtain access to the case solutions, please e-mail us or mail a request on your school letterhead to: The specific accounting would depend on the facts and circumstances.
For example, the most widely accepted view on an early termination of equity structures is predominantly to treat the event as a debt extinguishment; modifications of debt structures may be viewed as a troubled debt restructuring or a modification or exchange of debt instruments.
The Trueblood case studies prepared by Deloitte professionals are based on recent technical issues that often require significant research and judgment. Some companies have recently been revisiting their capital structures, including both equity and debt instruments, in response to changes in market conditions.
Box Stamford, CT The nonexclusive right to reproduce material contained in these cases without explicit written permission is hereby granted to faculty in connection with classroom use, academic research, and other educational endeavors of a not-for-profit nature.
For example, some companies have modified outstanding instruments, exercised early termination clauses, or exercised put or call options that were triggered by market events or conditions.Case Hemo-Tech Inc.
Part I Hemo-Tech Inc.
(“Hemo”) manufactures and sells specialized medical equipment and services to physicians and hospitals. The equipment is used to extract and store blood samples from patients. To Recognize or Not to Recognize, That Is the Question Shakespeare Inc.
(Shakespeare or the “Company”) is a privately held book printing and publishing company with a December 31 year-end. Deloitte Trueblood Case - Part Professional Accounting I Assignment #2 1 - Deloitte Trueblood Case introduction.
For the equipment Hemo-Tech should use its best estimate of selling price. Deloitte Case XXXXXXX BONER TITS REST OF PAPER IS LEGIT Deloitte Trueblood Case The case of “Pharmagen Pharmaceutical Development Funding” deals with a private equity investor who gives $ million to Pharmagen Pharmaceutical for research and development of a new drug “X”.
Trueblood Case "Deloitte Trueblood Case 12 04" Essays and Research Papers. Deloitte Trueblood Case 12 Case Hemo-Tech Inc.
Part I Hemo-Tech Inc. (“Hemo”) manufactures and sells specialized medical equipment and services to physicians and hospitals. The equipment is used to extract and store blood samples from patients.
The Trueblood case studies prepared by Deloitte professionals are based on recent technical issues that often require significant research and judgment. The case topics highlight the “gray” areas of accounting and help prepare students for the types of questions likely to arise in professional practice.Download